While near all heart disease is regulated by modifiable risk factors related to diet and lifestyle, once triggered it may be very hard to reverse. The good news is ongoing research at distinguished Medical Universities is demonstrating impressive reversal of heart disease markers.
2016 brings no end to new areas of heart health analysis and newly designed treatments directed by Big Pharma. Pharma’s medical influence continues to press plaque control, rather than elimination of plaque which has surfaced in recent progressive human trials of natural formulas. Unfortunately, the best Pharma’s misguided effort delivers is its recent “Track Your Plaque” program, reputed to be the most comprehensive solution to heart health available today – clearly it is not.
Medical Facilities collaborating data on ‘human-trial-proven natural modalities’, are demonstrating tangible genuine heart disease reversals. The 1998 Nobel Prize in Medicine went to “nitric oxide”, a powerful vasodilator which simply means to help keep your arteries open and maintain their smooth, Teflon-like texture so blood can flow normally. Nitric oxide should not be confused with nitrous oxide, which is laughing gas.
But it doesn’t have to be this way. An epic study shows that specific supplementation can reduce or even eliminate your risk of heart disease – without resorting to statin drugs. Heart specialists agree combating heart disease with supplements isn’t just safer… …it’s far more effective too. Remember the 1998 Nobel Medical Prize ? Well, L-arginine is a vital amino acid affecting a number of physiological functions in the body, and is best known for its cardiovascular benefits. In the body, L-arginine is converted to nitric oxide, which relaxes blood vessels and regulates their tone and flexibility. This reduces stress on the heart, improves circulation, and lowers BP.
Don’t miss this simple way to eliminate the single highest risk of death to the human race. L-arginine reduces BP by relaxing and healing inflamed arteries. It cleans out plaque so your blood flows without restrictions. Patients already using drugs to control HBP, further reduced systolic blood pressure and diastolic blood pressure with L-arginine, often lowering or eliminating prescriptions. L-arginine increased blood flow to the legs, healed inflamed arteries, rapidly normalized cholesterol levels, and significantly reduced triglycerides and bad LDL cholesterol, while significantly raising good HDL cholesterol. It is good HDL blood levels, which heart specialists agree are the most important factor of all in heart disease markers.
Many diabetics who otherwise die from heart disease, are using L-arginine which makes the body much more sensitive to insulin, so they can reduce their dosages and in some cases stop taking insulin all together. Diabetics suffer from poor circulation and heart disease conditions, yet with L-Arginine these problems are greatly reduced and many times eliminated. As well many other “non-heart classified” illnesses are really about inadequate blood flow throughout the body, which is a cloaked form of heart disease.
In addition to the Nobel Prize Laureate, several of the World’s leading cardiovascular scholars have also made profound contributions in this arena and continue to propel this scientific emphasis forward. Noteworthy is Dr. Joseph Prendergast MD, awarded “2008 Father of the year” by the American Diabetes Assoc, for “saving more lives than any other physician in the United States.” Prendergast is a formulator and works closely with John P. Cooke, PhD, world leader of cardiovascular science from Stanford University, Victor J. Dzau, from Duke University who is currently chancellor for health affairs and President and CEO of Duke University Health System, and Bryan Williams, MD, PhD, the number one cardiologist in Europe from Leicester University in England who just ended his tenure as President of the British Heart Foundation. For decades, these individuals have been isolating and scientifically validating the significant benefits nitric oxide offers in the many processes of the human body.
PDR Health. L-Arginine. 2007. Available at: http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/lar_0024.shtml
Romeroa MJ, Platt DH, Caldwell RB, Caldwell RW. Therapeutic use of Citrulline in Cardivascular Disease.
Pub Med: Zern TL, Fernandez ML. Cardioprotective effects of Dietary Polyphenols. The Journal of Nutrition.
Shoji T, Nishizawa Y. Effects of Vitamin D on the Cardiovascular System. Clinical Calcium. 2006 Jul;16(7):1107-14.
Wu-Wong JR, Tian J, Nakane M, Ma J, Fey TA, Kroeger P, Fryer RM. Cardivascular Disease in Chronic Kidney Failure:
Mehta S, Stewart DJ, Langleben D, et al. Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension.
Kimber J, Watson L, Mathias CJ. Cardiovascular and neurohormonal responses to i. v. l-arginine J Neurol 2001;248(12).
Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol.